Do people with RA face higher MS risk? What to know

Credibility

Interest

Key Takeaway

Overall, having rheumatoid arthritis (RA) did not raise the chance of developing multiple sclerosis (MS), but young women with a certain RA type may have a higher risk and should be watched closely.

What They Found

Researchers looked at health records across Poland from 2009–2021 to see how often people with RA also had MS. In the whole group, the number of people living with MS went up over time, but the number of new MS cases each year went down and people were older when they were diagnosed. Out of more than 300,000 people with RA, 464 also had MS, while 813 people had MS in a matched group without RA, so overall RA did not mean a higher MS risk. When the team looked at smaller groups by age and sex, young women (ages 16–39) with RA had more MS than similar young women without RA — about 37 vs 27 MS cases per 10,000 people. Older women with RA actually had lower MS rates, and death rates were similar whether people had RA or not.

Who Should Care and Why

People with RA and their caregivers should know that, for most patients, RA does not make MS more likely, which can be reassuring. Young women with RA — especially those with seronegative RA (this means common blood tests for RA were negative) — should pay attention because the study found a higher MS rate in this group. Doctors and nurses who care for people with RA should stay alert for unusual symptoms that could be MS, like new balance problems, vision changes, or unexplained numbness. Think of it like watching for a second, less common problem early: catching it sooner can help manage it better. This information can help families and care teams decide when to ask for a neurologist referral or extra tests.

Important Considerations

This was a pilot study that used health billing records, which can miss details doctors would collect in clinic visits, so the results are not final. The study can show patterns but cannot prove that RA causes MS — it can only say how often they appeared together. Also, the finding about young women and seronegative RA needs more research before changing care rules, because the number of cases in those subgroups was small and might not apply everywhere.

Categories:

MS Progression Epidemiology MS Diagnostics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Polish archives of internal medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News